SCHEMBL3157295

SCHEMBL3157295

CC(C)C#CCl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3366828 0.72
SCHEMBL512396 0.71
SCHEMBL6800593 0.69
SCHEMBL7637610 0.69
SCHEMBL7637607 0.69
SCHEMBL11335937 0.69
SCHEMBL6549803 0.69
SCHEMBL11259895 0.67
SCHEMBL4595200 0.64 TSHR (0.36)
SCHEMBL7629798 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024106438-A1 AMIDE COMPOUNDS OR SALTS THEREOF, BACTERICIDAL AGENTS FOR AGRICULTURE AND HORTICULTURE CONTAINING SAID COMPOUNDS, AND METHOD OF USING SAME 日本農薬株式会社 2024-05-23 WO disclosed
US-20240002354-A1 ANTIDIABETIC COMPOUNDS AND COMPOSITIONS REZUBIO PHARMACEUTICALS CO., LTD (CN) 2024-01-04 US disclosed
WO-2022028317-A1 ANTIDIABETIC COMPOUNDS AND COMPOSITIONS REZUBIO PHARMACEUTICALS CO., LTD (CN) 2022-02-10 WO disclosed
US-20100081693-A1 THIADIAZOLE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-04-01 US disclosed
CN-101516878-A Thiadiazole compound and use thereof SUMITOMO CHEMICAL CO (JP) 2009-08-26 CN disclosed
US-20070043011-A1 Substituted benzanilide compound and noxious organism controlling agent MITSUBISHI TANABE PHARMA CORPORATION (JP) 2007-02-22 US disclosed
EP-1671941-A1 SUBSTITUTED BENZANILIDE COMPOUND AND PEST CONTROL AGENT Nissan Chemical Industries, Ltd. (JP) 2006-06-21 EP disclosed
US-20050250822-A1 Substituted benzanilide compound and noxious organism controlling agent NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2005-11-10 US disclosed
EP-1538138-A1 SUBSTITUTED BENZANILIDE COMPOUND AND PEST CONTROL AGENT NISSAN CHEMICAL INDUSTRIES, LIMITED (JP) 2005-06-08 EP disclosed
US-6413998-B1 BONE REGENERATION OSTEOSCREEN, INC. 2002-07-02 US disclosed
US-6380452-B1 USING A FLUORINATED POLYETHERSULFONE POLYMER UOP LLC 2002-04-30 US disclosed
US-6281405-B1 PASSING ALKYLATING AGENT AND ALKYLATION SUBSTRATE TO ALKYLATION REACTION ZONE, ALKYLATING SUBSTRATE WITH ALKYLATING PASSING PORTION OF REACTION EFFLUENT STREAM TO A PRODUCT SEPARATION ZONE OPERATING AT CONDITIONS TO SEPA UOP LLC 2001-08-28 US disclosed
EP-0866710-A4 COMPOSITIONS AND METHODS FOR TREATING BONE DEFICIT CONDITIONS ZYMOGENETICS INC (US) 2001-07-11 EP disclosed
US-6248931-B1 USING A SULFONATED HEXAFLURO BIS-A-POLYETHER SULFONE MEMBRANE UOP LLC 2001-06-19 US disclosed
US-6008208-A Compositions and methods for treating bone deficit conditions OSTEOSCREEN, INC. (US) 1999-12-28 US disclosed
EP-0866710-A1 COMPOSITIONS AND METHODS FOR TREATING BONE DEFICIT CONDITIONS ZymoGenetics, Inc. (US) 1998-09-30 EP disclosed
WO-1997015308-A9 COMPOSITIONS AND METHODS FOR TREATING BONE DEFICIT CONDITIONS 1997-06-26 WO disclosed
WO-1997015308-A1 COMPOSITIONS AND METHODS FOR TREATING BONE DEFICIT CONDITIONS ZYMOGENETICS, INC. (US) 1997-05-01 WO disclosed